Scorpius Holdings, Inc. (1HB.F)

0.1280 0.0000 (0.00%) 收市：08:16AM CEST

Scorpius Holdings, Inc.

627 Davis Drive
Suite 400
Morrisville, NC 27560
United States
919 240 7133
https://www.scorpiusbiologics.com

版塊: Healthcare
行業: Biotechnology
全職員工: 82

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Jeffrey Alan Wolf J.D.	Founder, Chairman & CEO	528.83k	無	1963
Mr. William L. Ostrander	CFO & Secretary	344.89k	無	1968
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D.	Chief Medical Advisor and Member of Scientific & Clinical Advisory Board	無	無	無
Colonel George E. Peoples Jr., F.A.C.S., M.D.	Chief Medical Advisor	無	無	無
Ms. Ania Szymanska	Site Head of Quality	無	無	無
Mr. Joe Payne	President & COO of Scorpius BioManufacturing	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

公司管治

截至 無 止，Scorpius Holdings, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。